Related Experiment Video
Updated: Aug 29, 2026

Calculating Heart Rate Variability from ECG Data from Youth with Cerebral Palsy During Active Video Game Sessions
Published on: June 5, 2019
Prognostic value of heart rate variability in patients with hypertrophic cardiomyopathy
Tatsuya Kawasaki1, Akihiro Azuma, Tomohiko Sakatani
1Department of Cardiology, Matushita Memorial Hospital, Morigu-chi city, Osaka, Japan. js-k@wf6.so-net.ne.jp
Insights
Heart rate variability analysis predicts heart failure in hypertrophic cardiomyopathy (HCM) patients. The high frequency component of heart rate variability is a key indicator of cardiac events in HCM.
Area of Science:
- Cardiology
- Physiology
- Medical Diagnostics
Background:
- Hypertrophic cardiomyopathy (HCM) is associated with impaired heart rate variability (HRV).
- The prognostic significance of HRV in HCM remains incompletely understood.
- Previous studies suggest a link between HRV and clinical outcomes in cardiovascular diseases.
Purpose of the Study:
- To investigate the prognostic value of HRV in a cohort of hypertrophic cardiomyopathy patients.
- To determine if specific HRV parameters can predict adverse cardiac events, including heart failure and sudden death.
- To identify independent predictors of cardiac events within the HCM population.
Main Methods:
- Utilized fast Fourier transformation on 24-hour Holter recordings from 73 clinically stable HCM patients.
- Calculated four spectral components of HRV: very low frequency, low frequency, high frequency, and total power.
- Monitored patients for 28 months to record cardiac events such as death or hospitalization for heart failure.
Main Results:
- Seven out of 73 HCM patients experienced cardiac events (death or heart failure hospitalization) during the follow-up period.
- The high frequency (HF) component of HRV was significantly lower in patients who experienced cardiac events compared to those who did not (3.78 vs. 4.43 ln(ms(2)), P=.045).
- Multivariate analysis identified the HF component as an independent predictor of cardiac events (RR=0.10, P=.023), while other HRV variables showed no significant differences.
Conclusions:
- Heart rate variability analysis, particularly the high frequency component, is a valuable predictor of heart failure events in hypertrophic cardiomyopathy patients.
- The prognostic value of HRV for predicting sudden death in HCM requires further investigation.
- HRV assessment may aid in risk stratification and management of HCM patients.
Abstract:
Hypertrophic cardiomyopathy (HCM) have been reported to display impaired heart rate variability, although little is known regarding its prognostic value. By using fast Fourier transformation of 24-hour Holter recordings in 73 HCM patients at a stable clinical condition, we computed 4 spectral components: very low frequency, low frequency, high frequency, and total power. During 28 months, 7 HCM patients experienced death or acquired hospitalization for heart failure. Sudden death did not occurred. High frequency component was lower in HCM patients with cardiac events than that in patients without cardiac events (3.78 +/- 0.66 vs. 4.43 +/- 0.92 In(ms(2)), P =.045). There were no significant differences in other heart rate variability variables between HCM patients with and without cardiac events. In multivariate analysis, high frequency component remained to be an independent predictor of cardiac events (relative risk=0.10, 95% CI 0.01-0.73, P =.023). Heart rate variability analysis is predictive of heart failure in our cohort of HCM patients, whereas its predictive value of sudden death remains unclear.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
